Showing results (81-90 of 404) with videos related to

Sort By:
Pageof 41
Plos One|January 4, 2014
Cisplatin or not in advanced gastric cancer: a systematic review and meta-analysisFausto Petrelli, Alberto Zaniboni, Andrea Coinu, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2015
Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studiesFausto Petrelli, Mary Cabiddu, Andrea Coinu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysisFausto Petrelli, Raffaele Ardito, Karen Borgonovo, et al.
Anti-Cancer Drugs|April 9, 2016
Neoadjuvant dose-dense chemotherapy for locally advanced breast cancer: a meta-analysis of published studiesFausto Petrelli, Andrea Coinu, Veronica Lonati, et al.
Annals of Surgical Oncology|March 17, 2017
Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 StudiesFausto Petrelli, Michele Ghidini, Sandro Barni, et al.
Clinical Genitourinary Cancer|May 12, 2015
Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 StudiesFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patientsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Medicine|July 2, 2016
Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Clinical Genitourinary Cancer|December 4, 2014
Enzalutamide after docetaxel and abiraterone acetate treatment in prostate cancer: a pooled analysis of 10 case seriesFausto Petrelli, Andrea Coinu, Karen Borgonovo, et al.
Pageof 41